Renuvion Combined with Liposuction Yields 50% Fewer Abdominoplasties, Higher Body-Q
Apyx Medical’s Renuvion combined with liposuction showed statistically higher patient-reported satisfaction (Body-Q 87.8 vs 73.8; p=0.03) and reduced abdominoplasty rates by over 50% (30.0% vs 67.1%) in a 113-patient retrospective study. Revision rates dropped to 12.0% versus 37.5% (p=0.038) with comparable complication rates (2.5% vs 2.7%).
1. Study Design and Patient Cohort
A 113-patient retrospective analysis compared outcomes of power-assisted liposuction alone versus liposuction followed by helium plasma radiofrequency using Renuvion over a minimum 12-month follow-up, all performed by a single surgeon to ensure consistency in technique and reporting.
2. Enhanced Patient Satisfaction
Patients treated with Renuvion reported a mean Body-Q score of 87.8 compared to 73.8 for conventional liposuction (p=0.03), and among those who did not undergo abdominoplasty, satisfaction with abdominal appearance improved to 68.8 versus 45.0 (p=0.039).
3. Lower Surgical Revision and Abdominoplasty Rates
The addition of Renuvion halved abdominoplasty rates to 30.0% from 67.1% and reduced revision surgeries to 12.0% versus 37.5% (p=0.038), while overall complication rates remained virtually unchanged at 2.5% compared to 2.7%.
4. Product Positioning and Market Impact
These outcomes reinforce the value proposition of Apyx Medical’s Renuvion technology and its integration into the AYON Body Contouring System, potentially driving adoption in an annual market of over two million liposuction procedures worldwide.